Miltefosine/Paromomycin

· Drugs for Neglected Diseases Initiative

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Miltefosine/Paromomycin, covering 2024-02-29 to 2024-02-29. Get the full timeline:

Most recent: Clinical Trial Update: Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa [Phase 3]

See pricing